These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 28181752)
1. Shall the pharmaceutical companies decide which trials to perform? Rogne S Tidsskr Nor Laegeforen; 2017 Feb; 137(3):183. PubMed ID: 28181752 [No Abstract] [Full Text] [Related]
2. Innovation-Innovation Tradeoffs in Drug Pricing. Sachs RE; Frakt AB Ann Intern Med; 2016 Dec; 165(12):871-872. PubMed ID: 27723887 [No Abstract] [Full Text] [Related]
3. Pharmaceutical research and development spending Ranked by percentage of revenue spent on research in 2015 ($ in millions). Mod Healthc; 2016 Oct; 46(41):35. PubMed ID: 30398790 [No Abstract] [Full Text] [Related]
4. Notable deals in the pharmaceutical industry in the fourth quarter of 2016. D'Souza P Drugs Today (Barc); 2017 Jan; 53(1):75-82. PubMed ID: 28387386 [TBL] [Abstract][Full Text] [Related]
5. Impact of COVID-19 on pharmaceutical external innovation sourcing. Robke L; Berghauser Pont L; Bongard J; Wurzer S; Smietana K; Moss R Nat Rev Drug Discov; 2020 Dec; 19(12):829. PubMed ID: 33173230 [No Abstract] [Full Text] [Related]
6. Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality. Outterson K; Gopinathan U; Clift C; So AD; Morel CM; Røttingen JA PLoS Med; 2016 Jun; 13(6):e1002043. PubMed ID: 27299990 [TBL] [Abstract][Full Text] [Related]
7. Pharmaceutical company-sponsored drug trials: what are we to believe? Shekelle P J Clin Epidemiol; 2010 Feb; 63(2):126-7. PubMed ID: 19836207 [No Abstract] [Full Text] [Related]
8. Industry sponsorship and selection of comparators in randomized clinical trials. Lathyris DN; Patsopoulos NA; Salanti G; Ioannidis JP Eur J Clin Invest; 2010 Feb; 40(2):172-82. PubMed ID: 20050879 [TBL] [Abstract][Full Text] [Related]
9. Support for trials of promising medications through the Pharmaceutical Benefits Scheme. A proposal for a new authority category. Glasziou PP Med J Aust; 1995 Jan; 162(1):33-6. PubMed ID: 7605432 [TBL] [Abstract][Full Text] [Related]
10. Good manners for the pharmaceutical industry. Rustin GJ; Crowther D Lancet; 1997 Aug; 350(9074):371. PubMed ID: 9251670 [No Abstract] [Full Text] [Related]
11. Commentary: Reconsidering Pharmaceutical Research and Development Investments. Gagnon MA Healthc Policy; 2023 Feb; 18(3):25-30. PubMed ID: 36917451 [TBL] [Abstract][Full Text] [Related]
12. Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor. Flacco ME; Manzoli L; Boccia S; Capasso L; Aleksovska K; Rosso A; Scaioli G; De Vito C; Siliquini R; Villari P; Ioannidis JP J Clin Epidemiol; 2015 Jul; 68(7):811-20. PubMed ID: 25748073 [TBL] [Abstract][Full Text] [Related]
13. Large clinical trials in epilepsy: funding by the NIH versus pharmaceutical industry. Privitera M Epilepsy Res; 2006 Jan; 68(1):52-6. PubMed ID: 16377139 [TBL] [Abstract][Full Text] [Related]